Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.

Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, Janneke van der Woude C, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK; International Primary Sclerosing Cholangitis Study Group (IPSCSG), Levy C.

Clin Gastroenterol Hepatol. 2019 May 14. pii: S1542-3565(19)30523-3. doi: 10.1016/j.cgh.2019.05.013. [Epub ahead of print]

2.

Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel.

Pate J, Gutierrez JA, Frenette CT, Goel A, Kumar S, Manch RA, Mena EA, Pockros PJ, Satapathy SK, Yimam KK, Gish RG.

BMJ Open Gastroenterol. 2019 Feb 1;6(1):e000256. doi: 10.1136/bmjgast-2018-000256. eCollection 2019.

3.

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E; UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D, Yu L, Bowlus CL, Franke A, Lie BA, Karlsen TH.

HLA. 2017 Oct;90(4):228-233. doi: 10.1111/tan.13076. Epub 2017 Jul 11.

PMID:
28695657
4.

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.

Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM; International PSC Study Group.

Gastroenterology. 2017 Jun;152(8):1975-1984.e8. doi: 10.1053/j.gastro.2017.02.038. Epub 2017 Mar 6.

5.

Patient tolerability of bowel preparation is associated with polyp detection rate during colonoscopy.

Holt EW, Yimam KK, Ma H, Shaw RE, Sundberg RA, Verhille MS.

J Gastrointestin Liver Dis. 2014 Jun;23(2):135-40.

6.

Diagnosis and classification of primary sclerosing cholangitis.

Yimam KK, Bowlus CL.

Autoimmun Rev. 2014 Apr-May;13(4-5):445-50. doi: 10.1016/j.autrev.2014.01.040. Epub 2014 Jan 11. Review.

PMID:
24424180
7.

A Rare Case of Icteric Acute Hepatitis C Infection Acquired Through Intranasal Methamphetamine Use.

Chou C, Yimam KK, Frederick RT, Swenson SL.

ACG Case Rep J. 2014 Jan 10;1(2):112-4. doi: 10.14309/crj.2014.18. eCollection 2014 Jan.

8.

A rare case of acute hepatitis B virus infection causing guillain-barré syndrome.

Yimam KK, Merriman RB, Todd Frederick R.

Gastroenterol Hepatol (N Y). 2013 Feb;9(2):121-3. No abstract available.

9.

Esophageal adenocarcinoma in a 40-year-old man with cystic fibrosis: coincidence or not?

Holt EW, Yimam KK, Liberman MS.

Ochsner J. 2013 Summer;13(2):252-5.

10.

Every polyp counts: getting the most out of colonoscopy.

Holt EW, Yimam KK, Verhille MS.

Gastrointest Endosc. 2012 Oct;76(4):923; author reply 923-4. doi: 10.1016/j.gie.2012.05.021. No abstract available.

PMID:
22985653

Supplemental Content

Loading ...
Support Center